Rousset et al., 2001 - Google Patents
Functional roles of γ2, γ3 and γ4, three new Ca2+ channel subunits, in P/Q‐type Ca2+ channel expressed in Xenopus oocytesRousset et al., 2001
View PDF- Document ID
- 6423552421191850126
- Author
- Rousset M
- Cens T
- Restituito S
- Barrere C
- Black III J
- McEnery M
- Charnet P
- Publication year
- Publication venue
- The Journal of Physiology
External Links
Snippet
1 Stargazin or γ2, the product of the gene mutated in the stargazer mouse, is a homologue of the γ1 protein, an accessory subunit of the skeletal muscle L‐type Ca2+ channel. γ2 is selectively expressed in the brain, and considered to be a putative neuronal Ca2+ channel …
- 210000000287 oocyte 0 title abstract description 39
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/944—Acetylcholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rousset et al. | Functional roles of γ2, γ3 and γ4, three new Ca2+ channel subunits, in P/Q‐type Ca2+ channel expressed in Xenopus oocytes | |
| Chemin et al. | Specific contribution of human T‐type calcium channel isotypes (α1G, α1H and α1I) to neuronal excitability | |
| Kaczmarek | Slack, slick, and sodium‐activated potassium channels | |
| Betz et al. | Glycine receptors: recent insights into their structural organization and functional diversity | |
| Kubo et al. | Control of rectification and permeation by two distinct sites after the second transmembrane region in Kir2. 1 K+ channel | |
| Blanchard et al. | Inhibition of voltage‐gated Na+ currents in sensory neurones by the sea anemone toxin APETx2 | |
| Cusdin et al. | Trafficking and cellular distribution of voltage‐gated sodium channels | |
| Warnat et al. | Phenotype of a recombinant store‐operated channel: highly selective permeation of Ca2+ | |
| Wakamori et al. | Auxiliary subunits operate as a molecular switch in determining gating behaviour of the unitary N‐type Ca2+ channel current in Xenopus oocytes | |
| Maffie et al. | Weighing the evidence for a ternary protein complex mediating A‐type K+ currents in neurons | |
| Amarillo et al. | Ternary Kv4. 2 channels recapitulate voltage‐dependent inactivation kinetics of A‐type K+ channels in cerebellar granule neurons | |
| Bayliss et al. | Neuromodulation of hypoglossal motoneurons: cellular and developmental mechanisms | |
| Kuruma et al. | Dynamics of calcium regulation of chloride currents in Xenopus oocytes | |
| Currie et al. | Differential facilitation of N‐and P/Q‐type calcium channels during trains of action potential‐like waveforms | |
| Orio et al. | Characteristics and physiological role of hyperpolarization activated currents in mouse cold thermoreceptors | |
| Finley et al. | βL–βM loop in the C‐terminal domain of G protein‐activated inwardly rectifying K+ channels is important for Gβγ subunit activation | |
| Bett et al. | Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel | |
| Kourrich | Sigma-1 receptor and neuronal excitability | |
| Rubinstein et al. | Divergent regulation of GIRK1 and GIRK2 subunits of the neuronal G protein gated K+ channel by GαiGDP and Gβγ | |
| Boehm et al. | Glycine receptors in cultured chick sympathetic neurons are excitatory and trigger neurotransmitter release | |
| Jäger et al. | Regulation of mammalian Shaker‐related K+ channels: evidence for non‐conducting closed and non‐conducting inactivated states | |
| Sokolov et al. | Modulation of slow inactivation in class A Ca2+ channels by β‐subunits | |
| Temburni et al. | Receptor targeting and heterogeneity at interneuronal nicotinic cholinergic synapses in vivo | |
| Davies et al. | Evidence for the formation of functionally distinct αβγε GABAA receptors | |
| Mark et al. | G protein modulation of recombinant P/Q‐type calcium channels by regulators of G protein signalling proteins |